Compositions, pharmaceuticals, foods, cosmetics

Abstract

To provide a composition containing a cis-type xanthophyll derivative that exhibits excellent storage stability due to suppressed isomerization to the trans type and allows for efficient intake of cis-type xanthophyll. [Solution] A composition containing a cis-type xanthophyll derivative.

Description

Technical Field

[0001] The present invention relates to compositions, pharmaceuticals, foods, and cosmetics.

Background Art

[0002] Since xanthophylls widely present in nature have a strong antioxidant effect and various excellent effects, they are used in a wide range of applications such as health foods, cosmetics, and food colorings. Xanthophyll is a kind of carotenoid, and many compounds such as lutein, zeaxanthin, β - cryptoxanthin, α - cryptoxanthin, capsanthin, capsorubin, and astaxanthin are known.

[0003] Xanthophyll has a structure composed of a polyene part consisting of a plurality of continuously conjugated carbon double bonds, end groups modified at both ends thereof, and oxygen atoms such as alcohol, ketone, epoxy, and carboxylic acid in the molecule. Xanthophyll generally exists mainly in the trans form in nature where all double bonds are in the trans form. In recent years, it has become clear that cis - type xanthophyll has higher bioavailability, accumulation, and physiological activities (such as antioxidant effect, eye fatigue relief, anti - cancer effect, anti - obesity effect, and skin quality improvement effect) than trans - type xanthophyll, and its intake has attracted attention.

[0004] For example, Patent Document 1 describes an invention related to a functional food having an eye fatigue relief effect and the like of cis - type astaxanthin.

[0005] Further, Patent Document 2 discloses a method for storing cis - type carotenoids, characterized by storing cis - type carotenoids in the presence of an antioxidant, an organic acid salt, or vegetable oil or shark liver oil.

Prior Art Documents

Patent Documents

[0006]

Patent Document 1

[0007] In nature, it exists partially as a cis isomer, and the cis isomer ratio is constant and stable within living organisms. However, once extracted, the cis xanthophyll readily changes and becomes unstable. In other words, during industrialization, it easily isomerizes from the cis form to the trans form due to the effects of heat during extraction and storage. In particular, when the cis and trans forms coexist at room temperature or low temperatures, which are favorable for distribution, isomerization to the trans form and decomposition proceed significantly, making it difficult to stably maintain and store the cis form.

[0008] Conventional storage methods for cis-type carotenoids, such as those described in Patent Document 2, do not provide sufficient stability, and there is a need for a composition that allows for more stable and efficient intake of cis-type xanthophyll.

[0009] The present invention has been made in view of these circumstances, and aims to provide a composition containing a cis-type xanthophyll derivative that suppresses isomerization to the trans type, has excellent storage stability, and allows for efficient intake of cis-type xanthophyll. [Means for solving the problem]

[0010] As a result of diligent research into the above-mentioned problems, the inventors of this invention have found that when a cis-type xanthophyll is used as a cis-type xanthophyll derivative in which a portion of the cis-type xanthophyll is replaced with other substituents, isomerization to the trans isomer is less likely to occur and the derivative is stable, thus completing the present invention. Furthermore, we found that by using a composition containing a specific cis-type xanthophyll derivative, cis-type xanthophyll can be ingested more stably and efficiently. Furthermore, we discovered that by coexisting a specific amount of a cis-type xanthophyll derivative with a cis-type xanthophyll, which is unstable on its own, the isomerization of the cis-type xanthophyll to the trans-isomer is suppressed, thereby improving storage stability.

[0011] The present invention has the following aspects. [1] A composition containing a cis-type xanthophyll derivative. [2] The composition according to [1], further comprising a cis-type xanthophyll, wherein the molar weight ratio of the cis-type xanthophyll to the cis-type xanthophyll derivative is 0.05 to 1000. [3] The composition according to [1] or [2], wherein the cis-type xanthophyll derivative comprises one or more cis-type xanthophyll derivatives selected from the group consisting of lipid esters of cis-type xanthophyll, glycosides of cis-type xanthophyll, fatty acid glycosides of cis-type xanthophyll, aliphatic ethers of cis-type xanthophyll, and sulfate esters of cis-type xanthophyll. [4] The composition according to any one of [1] to [3], wherein the cis-type xanthophyll derivative comprises lipid esters of cis-type xanthophyll. [5] The composition according to any one of [1] to [4], wherein the cis-type xanthophyll derivative comprises a lipid ester of cis-type xanthophyll with one or more fatty acids selected from the group consisting of palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, eicosapentaenoic acid, arachidonic acid, and docosahexaenoic acid. [6] The composition according to any one of [1] to [5], wherein the cis-type xanthophyll derivative comprises one or more cis-type xanthophyll derivatives selected from the group consisting of cis-type lutein derivatives, cis-type zeaxanthin derivatives, and cis-type astaxanthin derivatives. [7] The composition according to any one of [1] to [5], wherein the cis-type xanthophyll derivative comprises a cis-type lutein derivative. [8] The composition according to any one of [1] to [5], wherein the cis-type xanthophyll derivative comprises a cis-type zeaxanthin derivative. [9] The cis-xanthophyll derivative is a composition according to any one of [1] to [5], including a cis-astaxanthin derivative.

[10] A pharmaceutical product containing the composition according to any one of [1] to [9].

[11] A food product containing the composition according to any one of [1] to [9].

[12] A cosmetic product containing the composition according to any one of [1] to [9].

Advantages of the Invention

[0012] According to the present invention, it is possible to provide a composition containing a cis-xanthophyll derivative in which isomerization to the trans form is suppressed, excellent in storage stability, and capable of efficiently ingesting cis-xanthophyll.

Brief Description of the Drawings

[0013] [Figure 1] It is a chromatogram of the M extract. [Figure 2] It is a chromatogram of the M control. [Figure 3] It is a chromatogram of the M extract and the M control. [Figure 4] It is a chromatogram of the orange paprika extract. [Figure 5] It is a chromatogram of the red paprika extract. [Figure 6] It is a chromatogram of the persimmon extract. [Figure 7] It is a chromatogram of the saffron extract.

Modes for Carrying Out the Invention

[0014] (Composition) The composition of this embodiment contains a cis-xanthophyll derivative.

[0015] <Cis-xanthophyll derivative> The cis-xanthophyll derivative is a compound in which a part of cis-xanthophyll is replaced with other atoms or substituents.

[0016] Examples of xanthophylls in cis-type xanthophyll derivatives include lutein, zeaxanthin, nostoxanthin, caloxanthin, β-cryptoxanthin, α-cryptoxanthin, zeinoxanthin, astaxanthin, adonixanthin, adonirubin, 3-hydroxyechinenone, 3'-hydroxyechinenone, capsanthin, capsorbin, cucurbitaxanthin A, violaxanthin, antheraxanthin, neoxanthin, and f Examples include coxanthin, fucoxanthinol, amarauciaxanthin A, diatoxanthin, diazinoxanthin, rubixanthin, flavoxanthin, peridine, siphonaxanthin, mixol, 4-ketomixol, and their apocarotenoids: β-apo-8'-carotenool, β-apo-8'-carotenic acid, paracentrone, abscisic acid, zaxinone, crocetin, crocin, bixin, retinol, and retinoic acid. Among these, lutein, zeaxanthin, or astaxanthin are preferred. That is, the composition of this embodiment preferably contains one or more cis-xanthophyll derivatives selected from the group consisting of cis-lutein derivatives, cis-zeaxanthin derivatives, and cis-astaxanthin derivatives.

[0017] Cis-type lutein consists of a polyene chain made up of 10 conjugated double bonds and end groups (terminal groups) attached to both ends. In this specification, isomers containing at least one cis-type conjugated double bond in the polyene chain are referred to as cis-type lutein, and isomers in which all of the double bonds are in the trans-type are referred to as trans-type lutein.

[0018] Cis-type zeaxanthin consists of a polyene chain made up of 11 conjugated double bonds and endogroups (terminal groups) attached to both ends. In this specification, isomers containing at least one cis-type conjugated double bond of the polyene chain are referred to as cis-type zeaxanthin, and isomers in which all of the 11 conjugated double bonds are in the trans-type are referred to as trans-type zeaxanthin.

[0019] Cis-astaxanthin is composed of a conjugated system consisting of a polyene chain made up of 11 conjugated double bonds and end groups (terminal groups) containing keto groups attached to both ends. In this specification, isomers containing at least one cis-type conjugated double bond in the carbon polyene chain are referred to as cis-type astaxanthin, and isomers in which all double bonds are in the trans-type are referred to as trans-type astaxanthin.

[0020] Cis-type xanthophylls can be produced by isomerizing trans-type xanthophylls using methods known from the literature, such as those described in Patent Document 3 or Document 1 (Journal of the Japan Society for Food Engineering, Vol. 21, No. 1, pp. 1-10, Mar. 2020). Specifically, these methods include dissolving trans-type xanthophylls in organic solvents (dichloromethane, chloroform, acetone, ethyl acetate, etc.), vegetable oils (sesame oil, mustard oil, etc.), supercritical carbon dioxide, etc., and then heat-treating them, or using cis-type isomerization catalysts such as isothiocyanates, polysulfides, or iodine.

[0021] Examples of cis-type xanthophyll derivatives include lipid esters of cis-type xanthophyll, glycosides of cis-type xanthophyll, fatty acid glycosides of cis-type xanthophyll, aliphatic ethers of cis-type xanthophyll, and sulfate esters of cis-type xanthophyll.

[0022] • Cis-type xanthophyll lipid esters Lipids (fatty acids) in the lipid esters of cis-type xanthophylls include acetic acid, propionic acid, butyric acid, crotonic acid, valeric acid, isovaleric acid, caproic acid, enanthic acid, caprylic acid, peragolic acid, capric acid, undecylic acid, lauric acid, tridecylic acid, myristic acid, myristoleic acid, pentadecylic acid, palmitic acid, sapienic acid, palmitoleic acid, margaric acid, pinolenic acid, stearic acid, sevaleic acid, oleic acid, linoleic acid, eleostearic acid, alpha-linolenic acid, gamma-linolenic acid, and s Examples include thearidonic acid, calendic acid, vaccenic acid, pauric acid, elaidic acid, gadoleic acid, eicosenoic acid, arachidic acid, meadic acid, dihomo-γ-linolenic acid, eicosatrienoic acid, eicosapentaenoic acid, arachidonic acid, behenic acid, erucic acid, docosatetraenoic acid, docosapentaenoic acid, docosahexaenoic acid, lignoceric acid, nervonic acid, tetracosapentaenoic acid, tetracosahexaenoic acid, cerotic acid, montanic acid, melissic acid, etc. Preferably caprylic acid, capric acid, lauric acid, myric acid Examples include stic acid, myristoleic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, stearidonic acid, calendic acid, vaccenic acid, pauric acid, elaidic acid, eicosenoic acid, arachidic acid, dihomo-gamma-linolenic acid, eicosatrienoic acid, eicosapentaenoic acid, arachidonic acid, behenic acid, erucic acid, elaidic acid, docosatetraenoic acid, docosapentaenoic acid, docosahexaenoic acid, etc., and more preferably caprylic acid, capric acid, lavoneic acid, etc. Examples include uric acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, dihomo-gamma-linolenic acid, elaidic acid, eicosapentaenoic acid, arachidonic acid, and docosahexaenoic acid, and more preferably palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, eicosapentaenoic acid, arachidonic acid, elaidic acid, and docosahexaenoic acid.

[0023] The lipid ester of cis-type xanthophyll may be composed of a mixture of multiple lipid esters. In this mixture, the molar ratio of lipid to cis-type xanthophyll is preferably 0.0001 to 4, more preferably 0.001 to 4, even more preferably 0.01 to 4, and particularly preferably 0.02 to 4. For example, in a mixture of lipid esters of cis-type xanthophyll, the molar ratio of palmitic acid, stearic acid, elaidic acid, oleic acid, linoleic acid, linolenic acid, arachidonic acid, and docosahexaenoic acid to cis-type xanthophyll is preferably 0.0001 to 4, more preferably 0.001 to 4, even more preferably 0.01 to 4, and particularly preferably 0.02 to 4.

[0024] • Cis-type xanthophyll glycosides Examples of glycosides in cis-xanthophyll glycosides include glucose, xylose, arabinose, mannose, fucose, fructose, galactose, and polysaccharides containing these, with fucose, xylose, and more preferably glucose.

[0025] A cis-xanthophyll glycoside is a mixture of several glycosides, and the molar ratio of the glycosides fucose, xylose, lactose, and glucose to the cis-xanthophyll in the total weight is preferably 0.001 to 600, more preferably 0.01 to 400, even more preferably 0.01 to 100, and particularly preferably 0.01 to 10.

[0026] • Cis-type xanthophyll fatty acid glycosides Examples of fatty acid glycosides in cis-type xanthophyll fatty acid glycosides include glucose fatty acid esters. A mixture of multiple fatty acid glycosides can be used for cis-type xanthophyll fatty acid glycosides.

[0027] • Cis-type xanthophyll aliphatic ethers Examples of cis xanthophyll aliphatic ethers include those that are generally known. A cis-type xanthophyll aliphatic ether can be a mixture of multiple aliphatic ethers.

[0028] • Sulfate esters of cis-type xanthophyll Examples of sulfate esters of cis-type xanthophylls include those that are generally known. A mixture of multiple cis-type xanthophyll sulfate esters can be used as the sulfate ester of the cis-type xanthophyll.

[0029] Because cis-type xanthophyll derivatives have a cyclic group with one hydroxyl group at either end of a polyene chain consisting of a conjugated double bond, the molecule as a whole has 1 to 2 hydroxyl groups. Therefore, mono-isomers, di-isomers and mixtures thereof can exist, including monoesters and diesters and mixtures thereof, monoglycosides, diglycosides and mixtures thereof, monolipid glycosides, dilipid glycosides and mixtures thereof, monoaliphatic ethers, dialiphatic ethers and mixtures thereof, sulfate monoesters, sulfate diesters and mixtures thereof. In the present invention, any of the mono-isomer, di-isomer, and mixtures thereof can be used. In the case of a mixture of mono-isomers and di-isomers, the mixing ratio (mono-isomer:di-isomer) is preferably 1:100 to 100:1, more preferably 1:50 to 50:1, even more preferably 1:25 to 25:1, particularly preferably 1:16 to 16:1, and most preferably in the range of 1:10 to 10:1. The relative abundances of mono-forms, di-forms, and mixtures thereof can be determined by high-performance liquid chromatography (HPLC) or thin-layer chromatography (TLC).

[0030] Cis-type xanthophyll derivatives can be produced by converting trans-type xanthophyll to lipid esters, glycosides, fatty acid glycosides, aliphatic ethers, or sulfate esters using generally known methods, and then isomerizing them, for example, by the method described in Reference 1 above. Isomerization from trans-type to cis-type can be confirmed by HPLC. Furthermore, trans xanthophylls can be commercially available, and chemically synthesized or naturally derived xanthophylls, as well as mixtures thereof, can be used.

[0031] For example, cis xanthophyll lipid esters can be produced by reacting trans xanthophyll with lipids to form trans xanthophyll lipid esters, which are then isomerized by the method described in Reference 1. Trans xanthophyll can be produced by generally known synthesis methods, or biological raw materials such as microalgae like the green alga Haematococcus, yeasts like the red yeast Phaffia, and crustaceans of arthropods such as shrimp, krill, crabs, and Daphnia, as well as their extracts, can be used.

[0032] For example, cis xanthophyll glycosides can be produced by reacting trans xanthophyll with a glycoside to form trans xanthophyll glycosides, and then isomerizing them using the method described in Reference 1.

[0033] For example, cis xanthophyll fatty acid glycosides can be produced by reacting trans xanthophyll with a fatty acid glycoside to form trans xanthophyll fatty acid glycosides, and then isomerizing them using the method described in Reference 1 above.

[0034] For example, cis xanthophyll aliphatic ethers can be produced by converting trans xanthophyll to trans xanthophyll aliphatic ethers using a generally known reaction, and then isomerizing them using the method described in Reference 1.

[0035] For example, cis xanthophyll sulfate esters can be produced by reacting trans xanthophyll with a sulfated glycoside to form trans xanthophyll sulfate esters, and then isomerizing them using the method described in Reference 1.

[0036] The composition of this embodiment may contain trans xanthophyll derivatives, but the proportion of cis xanthophyll derivatives in the total xanthophyll derivatives of the composition of this embodiment is preferably 30% or more, more preferably 35% or more, even more preferably 40% or more, and particularly preferably 45% or more.

[0037] <Optional ingredients> The composition of this embodiment may contain optional components other than the cis-type xanthophyll derivative described above. Optional components include cis-type xanthophyll, antioxidants, and additives.

[0038] ≪Cis-type xanthophyll≫ Cis-type xanthophylls are free forms in which all hydroxyl groups and carboxylic acids in the xanthophyll have not been derivatized by esterification or other means.

[0039] By coexisting a cis-xanthophyll derivative with a cis-xanthophyll, which is unstable on its own, the isomerization of the cis-xanthophyll to its trans isomer can be suppressed, thereby improving storage stability.

[0040] In the composition of this embodiment, the content (molar ratio) of the cis-type xanthophyll derivative to the content of the cis-type xanthophyll is preferably 0.05 to 1000, more preferably 0.1 to 100, and even more preferably 1 to 10.

[0041] The composition of this embodiment may contain trans xanthophyll. When the composition of this embodiment contains trans xanthophyll, the content (molar ratio) of trans xanthophyll to the content of cis xanthophyll is preferably 0.05 to 60, more preferably 0.05 to 40, and even more preferably 0.1 to 20.

[0042] Antioxidants Examples of antioxidants include compounds having phenolic hydroxyl groups; amine compounds such as phenylenediamines like diphenyl-p-phenylenediamine and 4-amino-p-diphenylamine; ascorbic acid; and oil-soluble derivatives of erythorbic acid. Specifically, examples of compounds having phenolic hydroxyl groups include guaiac oil; nordihydroguaiaretic acid (NDGA); gallate esters such as propyl gallate, butyl gallate, and octyl gallate; BHT (butylhydroxytoluene); BHA (butylhydroxyanisole); tocopherols (vitamin E; hereafter, VE) such as mixed tocopherols; tocotrienols and bisphenols. Among the above, tocopherols are preferred as antioxidants.

[0043] ≪Additives≫ Examples of additives include solvents, solubilizers, lubricants, emulsifiers, isotonic agents, preservatives, surfactants, pH adjusters, buffers, excipients, sweeteners, or flavorings.

[0044] ·solvent Examples of solvents include monoglycerides, diglycerides, and triglycerides, and specifically include olive oil, camellia oil, macadamia nut oil, castor oil, avocado oil, evening primrose oil, turtle oil, corn oil, mink oil, rapeseed oil, egg yolk oil, sesame oil, peach kernel oil, wheat germ oil, sasanqua oil, linseed oil, safflower oil, cottonseed oil, elm oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnamon oil, Japanese tung oil, jojoba oil, wheat germ oil, glyceryl trioctanoate, glyceryl triisopalmitate, salad oil, safflower oil, palm oil, coconut oil, peanut oil, almond oil, hazelnut oil, walnut oil, and grapeseed oil.

[0045] ·lubricant Examples of lubricants include acacia powder, cocoa butter, carnauba wax, carmellose calcium, carmellose sodium, caropeptide, hydrated silicon dioxide, dried aluminum hydroxide gel, glycerin, magnesium silicate, light anhydrous silicic acid, light liquid paraffin, crystalline cellulose, hydrogenated oil, synthetic aluminum silicate, sesame oil, wheat starch, bleached beeswax, magnesium oxide, dimethylpolysiloxane, potassium sodium tartrate, sucrose fatty acid ester, glycerin fatty acid ester, silicone resin, aluminum hydroxide gel, stearyl alcohol, stearic acid, aluminum stearate, calcium stearate Examples include um, polyoxyl stearate, magnesium stearate, cetanol, gelatin, talc, magnesium carbonate, precipitated calcium carbonate, corn starch, lactose, hard fat, sucrose, potato starch, hydroxypropyl cellulose, fumaric acid, sodium stearyl fumarate, polyethylene glycol, polyoxyethylene polyoxypropylene glycol, polysorbate, beeswax, magnesium aluminometasilicate, methylcellulose, Japanese wax, glyceryl monostearate, sodium lauryl sulfate, calcium sulfate, magnesium sulfate, liquid paraffin, phosphoric acid, etc.

[0046] • Solubilizer Examples of solubilizers include nonionic surfactants such as polyoxyethylene sorbitan monooleate (polysorbate 80), polyoxyethylene monostearate, and polyoxyethylene hydrogenated castor oil, as well as polyethylene glycol.

[0047] ·emulsifier Examples of emulsifiers include sucrose fatty acid esters, polysorbates, polyglycerol fatty acid esters, lecithin, and lysolecithin.

[0048] ·Isotonicity agent Examples of isotonic agents include sugars such as sorbitol, glucose, and mannitol, polyhydric alcohols such as glycerin and propylene glycol, and sodium chloride.

[0049] Preservatives Examples of preservatives include quaternary ammonium salts such as benzalkonium chloride, benzethonium chloride, and cetylpyridinium chloride; parahydroxybenzoic acid esters such as methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, and butyl parahydroxybenzoate; benzyl alcohol, phenethyl alcohol, sorbic acid and their salts; thimerosal; chlorobutanol; and sodium dehydroacetate.

[0050] • Surfactants Examples of surfactants include sucrose fatty acid esters, propylene glycol esters, glycerin fatty acid esters, sorbitan fatty acid esters, dextrin, and reduced dextrin.

[0051] • pH adjuster Examples of pH adjusting agents include hydrochloric acid, phosphoric acid, acetic acid, tartaric acid, sodium hydroxide, potassium hydroxide, sodium carbonate, and sodium bicarbonate.

[0052] • Buffer Examples of buffering agents include phosphate buffers, tartrate buffers, and amino acids.

[0053] • Excipients Excipients include lactose, sucrose, mannitol, corn starch, and crystalline cellulose.

[0054] [Application] The composition of this embodiment can be used in applications such as food, beverages, functional foods, nutritional supplements, pharmaceuticals, quasi-drugs, cosmetics, veterinary drugs, pet food, feed, or animal feed.

[0055] The content of the cis-type xanthophyll derivative and cis-type xanthophyll is preferably 0.5 to 40% by mass, more preferably 1 to 30% by mass, and even more preferably 5 to 20% by mass, relative to the total product.

[0056] The composition of this embodiment can be formulated with commonly known additives to suit its purpose and can be in the form of oil, powder, emulsion, etc. [Examples]

[0057] The present invention will be described in more detail below with reference to examples, comparative examples, and test examples, but the present invention is not limited thereto.

[0058] 1. Cis-isomerization of astaxanthin derivatives (batch method) The fatty acid ester of trans astaxanthin was produced by heating and rapidly cooling the fatty acid ester of trans astaxanthin using the following procedure. As a raw material, we used Haematococcus pluvialis pigment A (hereinafter also simply referred to as "Haematococcus pluvialis pigment A") which contains 10% by mass of trans-astaxanthin fatty acid esters in terms of free astaxanthin. The remaining 90% by mass of Haematococcus algal pigment A consists of neutral fats such as triglycerides and diglycerides. The fatty acid ester of trans-astaxanthin in Haematococcus algae pigment A is composed of trans-astaxanthin derived from Haematococcus algae and a mixture of fatty acids (a mixture of palmitic acid, elaidic acid, oleic acid, linoleic acid, linolenic acid, arachidonic acid, and eicosapentaenoic acid, etc.). Analysis confirmed that more than 99.9% of the fatty acid ester of trans-astaxanthin is in the ester form. This fatty acid ester of trans-astaxanthin is a fatty acid ester of trans-astaxanthin that meets the specifications of Non-Patent Literature A below.

[0059] We have not analyzed the ratio of each fatty acid constituting the fatty acid ester of trans-astaxanthin. On the other hand, Non-Patent Documents B and C below disclose the ratio of each fatty acid in the fatty acid ester of trans-astaxanthin produced using similar trans-astaxanthin and fatty acids. Therefore, it is presumed that the ratio of each fatty acid in the fatty acid ester of trans-astaxanthin in this trans-astaxanthin is similar to the ratio of each fatty acid in the fatty acid ester of trans-astaxanthin described in Non-Patent Documents B and C. Non-patent documents B and C disclose the ratio of each fatty acid in the fatty acid ester of trans astaxanthin as palmitic acid (15-35%), elaidic acid (10-20%), oleic acid (10-20%), linoleic acid (15-35%), linolenic acid (0.1-10%), arachidonic acid (~1%), and eicosapentaenoic acid (~1%).

[0060] Non-patent document A: According to the Union list of novel foods (Commission Implementing Regulation (EU) 2017 / 2470). Non-patent document B: Ruiz-Dominguez MC, Espinosa C, Paredes A, Palma J, Jaime C, Vilchez C, Cerezal P. Determining the Potential of Haematococcus pluvialis Oleoresin as a Rich Source of Antioxidants. Molecules. 2019 Nov 11;24(22):4073. doi: 10.3390 / molecules24224073. PMID: 31717936; PMCID: PMC6891815. Non-Patent Document C:Mahadi, R.; Vahisan, LPS; Ilhamsyah, DPA; Kim, S.; Kim, B.; Lee, N.; Oh, Y.-K. Enhancement of Astaxanthin and Fatty Acid Production in Haematococcus pluvialis Using Strigolactone. Appl. Sci. 2022, 12, 1791.

[0061] 2 g of Haematococcus algae pigment A was weighed into a 9 mL capped glass container (NWT-18; manufactured by Maruemu Co., Ltd.), the headspace was replaced with nitrogen, and the container was capped. Then, Haematococcus algae pigment A was heated in an oil bath (SOS-183D; manufactured by Sansho Co., Ltd.) at a temperature of 100-200°C for 5-60 minutes. After the reaction, the sample was rapidly cooled with ice to obtain an isomerized sample, and the isomerization efficiency was confirmed. The results are shown in Table 1 below.

[0062] The amount and isomers of astaxanthin were analyzed by high-performance liquid chromatography (HPLC), and the results were calculated from the peak area. Conditions for normal-phase HPLC analysis of compositions containing cis-type astaxanthin. Equipment: High-performance liquid chromatograph Prominence system (SPD-M20A, manufactured by Shimadzu Corporation) Column: Penomenex silica gel luna(2) (Length: 150mm x 2, Inner diameter: 4.6mm, Particle size: 5μm, manufactured by Penomenex) Mobile phase: Hexane / ethyl acetate / acetone (volume ratio 70:20:10) Flow rate: 1.2mL / min Detection wavelength: 470nm Column temperature: 40℃

[0063] [Table 1]

[0064] As shown in Table 1, the isomerization efficiency improved in a temperature-dependent manner, but decomposition was also accelerated. However, under appropriate temperature conditions, isomerization was possible in a short time while suppressing decomposition. For example, in the range of 30-60 minutes at 140°C, 10-30 minutes at 160°C, and 5-15 minutes at 180°C, it was possible to increase the proportion of the cis isomer to over 50% while suppressing the decomposition of astaxanthin ester (decomposition rate of 15% or less).

[0065] 2. Cis-isomerization of astaxanthin (sequence formula) Haematococcus algae pigment A was prepared to a 2% concentration using medium-chain fatty acid glycerides and used as a sample. The sample was subjected to an isomerization reaction by passing it through a drying oven set at 160, 200, and 240°C using a tube with an inner diameter of 0.2 cm. The length of the tube in the drying oven was 79.62 cm, and the liquid volume was 2.5 mL. Five flow rates of 0.5, 1.0, 2.5, 5.0, and 10.0 mL / min were investigated (the isomerization reaction times for the samples were 5.0, 2.5, 1.0, 0.5, and 0.25 minutes). After the reaction, the samples were rapidly cooled with ice to obtain the isomerized samples, and the isomerization efficiency was confirmed. The results are shown in Table 2 below.

[0066] [Table 2]

[0067] As shown in Table 2, it was possible to perform isomerization reactions using this apparatus.

[0068] 3. Scale-up testing of cis-isomerization To investigate the industrial compatibility of isomerization technology by heating, the effect of test scale on isomerization efficiency was examined. 2g and 25g of Haematococcus algae pigment A were weighed into 9mL capped glass containers (NWT-18; Maruemu Co., Ltd.) and 110mL capped glass containers (9-852-10; AS ONE Corporation), respectively. The headspace was purged with nitrogen, and the containers were capped. These glass containers were heated at 180°C for 15 minutes using an oil bath (SOS-183D; Sansho Co., Ltd.), and then immediately cooled rapidly in ice water. The ratio of the cis isomer of astaxanthin ester after treatment was 57.7% and 59.1% for the 2g and 25g inputs, respectively, and no decrease in isomerization efficiency due to scale-up was observed.

[0069] 4. Study on manufacturing methods using a mixture of astaxanthin ester and free form. 4-1 Isomerization after mixing astaxanthin ester and free form. An esterified solution was prepared by mixing 2 g of Haematococcus algae pigment A with 38 g of medium-chain fatty acid glycerides. A free-form solution was prepared by dissolving 0.2 g of free-form astaxanthin, 0.03 g of mixed tocopherols, and 39.77 g of medium-chain fatty acid glycerides in 20 mL of dichloromethane and sonicating for several seconds to completely dissolve them. Esterified solution:free-form solution were mixed in ratios of 10:0, 8:2, 5:5, 2:8, 1:9, and 0:10, and 3.0 g of each mixture was added to a glass reaction tube. The isomerization reaction was carried out in an oil bath at 180°C for 5 minutes. After the reaction, the mixture was rapidly cooled with ice and stored at 30°C and 40°C for one week, and the ratio of cis-form and the remaining astaxanthin percentage were measured. The results are shown in Table 3 below.

[0070] [Table 3]

[0071] When only the free form was used, the residual astaxanthin rate decreased significantly. On the other hand, a tendency was observed for the stability of the cis form to increase as the proportion of the ester form increased.

[0072] 4-2 When cis-form astaxanthin ester and free-form cis-form astaxanthin are mixed. Haematococcus algae pigment A was added to 3.0 g each of two glass reaction tubes, nitrogen was sealed in, and the isomerization reaction was carried out in an oil bath at 180°C for 5 minutes. After the reaction, it was rapidly cooled with ice, the reactants were combined and thoroughly mixed, and diluted with medium-chain fatty acid glycerides to an AX of 0.5% to prepare an ester solution. Free astaxanthin was subjected to a cis-isomerization reaction, and the unisomerized free astaxanthin was added to the previously prepared ester solution so that the cis-isomer content was equivalent, and then mixed. 28.80 mg of the mixture was added, along with 5.75 mg of mixed tocopherols. 5715.45 mg of medium-chain fatty acid glycerides were thoroughly mixed and dispersed by sonication to prepare a free-form solution. Ester and free-form solutions were mixed in ratios of 10:0, 8:2, 5:5, 2:8, 1:9, and 0:10, and stored at 30°C and 40°C for one week. The ratio of the cis-form and the remaining astaxanthin were measured. The results are shown in Table 4 below.

[0073] [Table 4]

[0074] As shown in Table 4, a tendency was observed for the stability of the cis isomer to increase with a higher proportion of the ester isomer.

[0075] 5. Powder manufacturing and stability testing To make cis-type astaxanthin derivatives more readily available for food applications, we investigated powder processing methods. For powdering, we performed organic solvent spray drying using a closed spray dryer (ADL311S; manufactured by Yamato Scientific). Ethanol was used as the solvent, and polyvinylpyrrolidone (PVP) or hydroxypropyl-β-cyclodextrin (HP-BC) was used as the excipient. To a solution of the excipient dissolved in ethanol, a cis-type astaxanthin derivative (obtained by heating Haematococcus algae pigment A at 140°C for 30 minutes and then rapidly cooling, as shown in Table 1 (total cis: 51.66%)) was added to a concentration of 0.1 mg / mL and completely dissolved. This solution was spray-dried at a flow rate of 5 mL / min to obtain a powder. As part of the spray-drying study, the inlet temperature and excipient concentration were investigated under the following conditions. Inlet temperature testing: 100°C, 120°C, 140°C (excipient concentration 10 mg / mL) Excipient concentration studies: 5, 10, 20 mg / mL (at 120°C) The results are shown in Tables 5 and 6 below. It was found that both excipients remained stable without isomerization from cis to trans during the spray-drying process.

[0076] [Table 5]

[0077] [Table 6]

[0078] Powder obtained under spraying conditions of an inlet temperature of 120°C and an excipient concentration of 10 mg / mL was stored at 5°C, 30°C, and 40°C for 1, 3, and 6 weeks, and the ratio of cis isomers and the remaining astaxanthin percentage were measured. The results are shown in Tables 7 and 8 below.

[0079] [Table 7]

[0080] [Table 8]

[0081] As shown in Tables 7 and 8, good results were obtained in terms of astaxanthin retention rates.

[0082] 6. Manufacturing and Stability Testing of Emulsified Products To further expand the applications of cis-type astaxanthin derivatives (the cis-type astaxanthin derivatives shown in Table 1 (total cis: 51.66%) obtained by heating Haematococcus algae pigment A at 140°C for 30 minutes and then rapidly cooling) we investigated emulsions. An emulsion was prepared by mixing 1.0 g of a cis-type astaxanthin derivative (a cis-type astaxanthin derivative shown in Table 1, obtained by heating Haematococcus algae pigment A at 140°C for 30 minutes and then rapidly cooling it (total cis: 51.66%)), 0.15 g of mixed tocopherols, 3.85 g of medium-chain fatty acid glycerides, and 5.0 g of sucrose fatty acid ester. DK ester-SS or decaglin 1-L was used as the sucrose fatty acid ester. The resulting emulsion was stored at 30°C for one week, and the ratio of the cis-isomer and the remaining astaxanthin percentage were measured. The results are shown below. The cis-isomer showed good stability in all emulsions.

[0083] [Table 9]

[0084] 7. Investigation of cis-isomerization of lutein and zeaxanthin derivatives Fatty acid esters of trans lutein and zeaxanthin were prepared by heating and rapidly cooling the fatty acid esters of trans lutein and zeaxanthin using the following procedure. Free trans lutein and zeaxanthin were also used as a control to examine the efficiency of cis-conjugation. A commercially available marigold extract supplement (lutein, Kirin Kyowa Hakko Bio Co., Ltd., hereinafter referred to as "M Extract") was used as a raw material. M Extract contains 8-13 mg of trans lutein as the main component in the form of fatty acid esters per two capsules (in free form equivalent), and also contains a small amount of trans zeaxanthin. It is also stated that it contains 2000 μg of β-carotene and 120 mg of bilberry (blueberry) extract. The remainder consists of edible olive oil and vitamin E-containing vegetable oil. As a comparative control, marigold-derived oleoresin (Katra Phytochem Pvt Ltd., India, hereinafter referred to as "M Control") containing free lutein and zeaxanthin was used. M Control is shown to contain 20% trans lutein as the main component (in free form equivalent), and also contains approximately 2% trans zeaxanthin (in free form equivalent). The remainder consists of neutral fats such as triglycerides and diglycerides. Based on reference A, the fatty acid composition of the lutein and zeaxanthin fatty acid esters in marigolds is estimated to be palmitic acid, stearic acid, myristic acid, and lauric acid. Two capsules were taken as the M extract and 52.6 mg of marigold-derived oleoresin was taken as the M control. Both were dissolved in 100 mL of methyl-tert-butyl ether (MTBE) containing 0.05% dibutylhydroxytoluene (BHT) as an antioxidant. The mixture was then washed several times with saturated sodium sulfate aqueous solution. In particular, the M extract was washed until the aqueous layer was completely colorless. A portion of the mixture was taken, dried under a nitrogen stream, redissolved in MTBE, and subjected to HPLC analysis. The HPLC gradient conditions and other conditions were set as described below and in Table 10, based on Reference B. In subsequent examples, the same HPLC conditions were used unless otherwise noted. (HPLC conditions) HPLC system: LC-2030 (manufactured by Shimadzu Corporation) Detector: Photodiode array detector (300-700nm) Column: YMC Carotenoid, Length: 250mm, Inner diameter: 4.6mm, Particle size: 5μm, Manufactured by YMC. Mobile phase A: methanol Mobile phase B: MTBE Mobile phase C: 1% phosphate: Flow rate: 1.0mL / min Detection wavelength: 450nm * Column temperature: 25℃ Under these conditions, the chromatogram was corrected based on the peak with the highest height.

[0085] [Table 10]

[0086] The chromatograms of the marigold extract are shown in Figures 1 and 2. Sample classification was determined based on retention time and absorption spectra of free trans lutein (maximum absorption at 445 nm) and trans zeaxanthin (maximum absorption at 450 nm). While very small amounts of free trans lutein and trans zeaxanthin were detected in the M extract, as described in reference B, the majority of the carotenoids showed complex peak shapes, likely representing a mixture of fatty acid esters of both (xanthophylls) and β-carotene. In contrast, the M control contained free trans lutein as the main component, along with some free trans zeaxanthin. Very small peaks of cis lutein and zeaxanthin (xanthophylls) were also observed.

[0087] Reference A: Cantrill, et al., 82nd JECFA - Chemical and Technical Assessment (CTA), FAO 2016. URL: https: / / openknowledge.fao.org / server / api / core / bitstreams / 6faebb16-6ba5-4791-9574-25690e11521d / content Reference B: Prado-Cabrero, Eur Food Res Technol (2016) 242:599-608

[0088] (Alkaline saponification treatment) 1 mL of the MTBE solution derived from the M extract and M control, as previously shown, was placed in a brown glass screw centrifuge tube, and 1 mL of 60% KOH / EtOH was added and the mixture was vigorously stirred. After stirring, saponification was performed at 50°C for 1 hour. Immediately after the treatment, 3 mL of MTBE and 3 mL of saturated sodium sulfate aqueous solution were added, and after vigorous stirring, the mixture was centrifuged at 3000 rpm for 10 minutes. After confirming separation into two layers, 3 mL of the upper layer was taken, concentrated as appropriate under a nitrogen stream, and subjected to HPLC. The HPLC results for the M extract and M control are shown in Figures 1 and 2. From Figures 1 and 2, excluding carotenes such as β-carotene, which are thought to have been incorporated into the supplement tablets, similar chromatograms were shown, with lutein as the main component, followed by zeaxanthin and its isomers. The M extract had a higher proportion of cis isomers of xanthophylls, and the ratio of cis isomers of cis-type xanthophylls to total xanthophylls was 17.5%. The esterification ratio of the M extract was estimated to be over 99%. No significant difference was observed in the chromatograms of the M control before and after cis-isomerization. However, a slight increase in cis-isomers (approximately 0.1%) was observed.

[0089] Cis-isomerization treatment: The entire MTBE extracts from the M extract and M control were dried under reduced pressure and dissolved in approximately 15 mL of commercially available MCT oil (Asahi Co., Ltd., Japan). A portion of the resulting oil was transferred to a glass tube and heated at 165°C for 30 minutes under a nitrogen stream (30 L / h). Immediately after the reaction, the heated samples were cooled with ice water, packed with nitrogen into brown sample tubes, and stored. 1 mL each of the heated M extract and M control were measured out, diluted with 9 mL of MTBE, and then subjected to the alkaline saponification treatment described in paragraph

[0087] . The obtained samples were concentrated as appropriate under a nitrogen stream and subjected to HPLC. The HPLC results for the M extract and M control are shown in Figure 3, and the series of comparative results are shown in Table 11. In Table 11, total F-type xanthophylls refer to total free-type xanthophylls.

[0090] [Table 11]

[0091] As shown in Figure 3, no significant changes were observed in the ester of the M extract that was not subjected to alkaline saponification before and after cis-isomerization. The M extract (ester derivative) and M control (free form) after alkaline saponification showed similar chromatograms, and compared with Figures 1 and 2, an increase in numerous peaks was observed, which were only slightly present before cis-isomerization. In addition, a significant decrease in the peak of trans-lutein, the main component, was observed. The newly appearing peaks showed a shift in UV / VIS absorption maxima to a wavelength 5-10 nm lower than that of all trans-lutein and zeaxanthin, with a cis-isomer-dependent maximum absorption appearing around 315-330 nm. Therefore, these peaks were considered to be cis-lutein and cis-zeaxanthin. The values ​​calculated from the total area of ​​these peaks are labeled as cis-xanthophyll in Table 11. Table 11 shows that although both originated from different sources, the ratio of cis-xanthophyll cis-isomers to total xanthophyll in the M extract (ester derivative) and M control (free form) was 53% and 55%, respectively. In summary, the results of this study demonstrate that, despite the different raw material forms of the free form and ester derivative, it is possible to obtain cis-type lutein and cis-type zeaxanthin with high efficiency by performing this cis-conjugation treatment method.

[0092] 8. Investigation of cis-isomerization of zeaxanthin derivatives derived from orange paprika Orange bell peppers are rich in zeaxanthin. Therefore, we attempted to synthesize cis-type xanthophyll derivatives, primarily zeaxanthin, using orange bell peppers as the raw material. Commercial orange bell peppers (Japanese origin) were frozen, and approximately 100g of the flesh, after removing the seeds, white pith, and stem, was measured out, chopped, and pureed in a juicer. Then, 40mL of ethanol was added to the entire puree and mixed well, followed by the addition of 40mL of methylene chloride and further vigorous mixing. The mixture was then stored in a refrigerator overnight. After that, 40mL of methylene chloride was added and mixed again, followed by the addition of 150mL of hexane and vigorous mixing. The mixture was then filtered through a tea strainer. The residue was washed several times with hexane and the solution was collected. After standing for a while, the filtrate separated into two layers. The upper layer was filtered using filter paper, transferred to a separatory funnel, washed several times with saturated saline solution, and dried under reduced pressure using an evaporator. The dried sample was dissolved in 50 mL of MTBE. A portion of this was taken and dried under a nitrogen stream, and both the unsaponified and alkali-saponified samples were analyzed by HPLC. In addition, for cis isomerization, the MTBE extract was dried under reduced pressure and dissolved in approximately 15 mL of MCT, and cis isomerization by heating was performed in the same manner as in Example 7. All conditions, including alkali saponification and HPLC gradient conditions, were the same as in Example 7. The results are shown in Figure 4.

[0093] The HPLC chromatogram results shown in Figure 4 indicate that approximately 58% of the pigment components consist of fatty acid ester derivatives of various xanthophylls and carotenes. Specifically, in the unsaponified sample, trans zeaxanthin (maximum absorption wavelength: 451 nm) was the main component as free xanthophylls, followed by trans lutein (maximum absorption wavelengths: 445 nm, 471 nm), with small amounts of trans β-cryptoxanthin (maximum absorption wavelength: 452 nm) and cis zeaxanthin (maximum absorption wavelengths: 446 nm, 339 nm). In addition, complex peaks were detected in the latter part of the elution. As a result of alkaline saponification, these complex peaks were found to be partly esters of carotenes and xanthophylls (mainly consisting of trans zeaxanthin, lutein, and β-cryptoxanthin). After cis-isomerization, alkaline saponification treatment revealed numerous peaks around the peaks of free zeaxanthin, free lutein, and free β-cryptoxanthin. In all of these peaks, the maximum absorption shifted 5-10 nm to a lower wavelength, and a cis-isomer-dependent maximum appeared around 330 nm, suggesting they were cis-type zeaxanthin, cis-type lutein, and cis-type β-cryptoxanthin. Similar peak fluctuations were observed for each component of carotene. In summary, the ratio of cis-isomers to trans-type xanthophylls was approximately 0.6%, but increased to approximately 48.6% after cis-isomerization. However, since the maximum absorption of cis-type peaks typically shifts to lower wavelengths, the actual proportion of cis-type xanthophylls is likely higher than this figure suggests.

[0094] 9. Investigation of cis-isomerization of xanthophyll derivatives mainly composed of capsanthin and zeaxanthin derived from red bell peppers. Red bell peppers are rich in unique xanthophylls such as capsanthin, capsorbin, and zeaxanthin. Therefore, we attempted to synthesize cis-type xanthophyll derivatives, primarily these xanthophylls, using red bell peppers as a raw material. Commercially available red bell peppers (Japanese origin) were frozen, and approximately 100g of the flesh, after removing the seeds, white pith, and stem, was measured out, shredded, and pureed in a juicer. Then, 40mL of EtOH was added to the entire puree and mixed well, followed by 40mL of methylene chloride, which was mixed vigorously again. The mixture was then stored in a refrigerator overnight. After that, 40mL of methylene chloride was added and mixed again, followed by 150mL of hexane, which was mixed and then filtered through a tea strainer. The residue was washed several times with hexane, and the filtrate separated into two layers. The upper layer was filtered using filter paper, transferred to a separatory funnel, washed several times with saturated saline solution, and dried under reduced pressure using an evaporator. The dried material was dissolved in 50mL of MTBE. A portion of this was taken and dried under a nitrogen stream, and the unsaponified sample and the alkali-saponified sample were analyzed by HPLC. Furthermore, for cis isomerization, the MTBE extract was dried under reduced pressure, dissolved in approximately 15 mL of MCT, and cis isomerization by heating was carried out in the same manner as in Example 7. The conditions for alkali saponification and HPLC gradient were the same as in Example 7. The results are shown in Figure 5.

[0095] The HPLC chromatogram results shown in Figure 5 indicated that approximately 90% consisted of fatty acid ester derivatives of various xanthophylls and carotenes. Specifically, in the unsaponified sample, the main free xanthophyll was trans-capsanthin (maximum absorption wavelength: 474 nm), along with trans-type zeaxanthin (maximum absorption wavelength: 451 nm), violaxanthin (maximum absorption wavelength: 428 nm, 478 nm), capsorbin (maximum absorption wavelength: 480 nm), and neoxanthin (maximum absorption wavelength: 423 nm, 447 nm), all of which were thought to be cis-type carotenoids. Furthermore, the majority of the components eluted in the latter half of the spectrum resulted in the detection of peaks with complex shapes. As a result of alkaline saponification, these complex peaks were found to be esters of carotenes and the aforementioned xanthophylls. After cis-conjugation treatment, alkaline saponification treatment was performed, and in all cases, peaks for trans-type neoxanthin, violaxanthin, capsanthin, zeaxanthin, and β-cryptoxanthin appeared, along with numerous other unidentified peaks. When the conversion efficiency by saponification treatment was evaluated after cis-conjugation treatment of the extract, inseparable smear peaks were detected around neoxanthin, violaxanthin, capsanthin, zeaxanthin, and β-cryptoxanthin. In all of these peaks, the maximum absorption shifted to a lower wavelength of 5-10 nm, and some showed a cis-isomer-dependent maximum around 330 nm, suggesting that they were mixtures of cis-type capsanthin, zeaxanthin, and β-cryptoxanthin. Similar peak fluctuations were also observed for each component of carotene. In summary, it was considered that more than 68% of the total xanthophylls in the composition were cis-type xanthophylls. Furthermore, since the maximum absorption of the cis-type peak is usually shifted to the lower wavelength side, it is thought that a higher proportion of cis-type xanthophyll is present than indicated by these figures.

[0096] 9. Investigation of cis-isomerization of β-cryptoxanthin and zeaxanthin derivatives derived from persimmon. Persimmons, like Satsuma mandarins, are rich in β-cryptoxanthin and zeaxanthin. Therefore, we attempted to synthesize cis-type xanthophyll derivatives, mainly β-cryptoxanthin, using persimmons as a raw material. Commercially available persimmons (Fuyu persimmons, Japanese) were frozen, approximately 25g of the peel was measured out, shredded, and pureed in a juicer. Subsequently, 40 mL of EtOH was added to the entire puree and mixed well. Then, 40 mL of methylene chloride was added and mixed vigorously again, and the mixture was stored in a refrigerator overnight. After that, 20 mL of saturated sodium sulfate aqueous solution and 40 mL of methylene chloride were added and mixed again. Then, 150 mL of hexane was added and mixed vigorously, and the mixture was filtered through a tea strainer. The residue was washed several times with hexane and the solution was collected. After standing for a while, the filtrate separated into two layers. The upper layer was filtered using filter paper, transferred to a separatory funnel, washed several times with saturated saline solution, and dried under reduced pressure using an evaporator. The dried material was dissolved in 50 mL of MTBE. A portion of this was taken and dried under a nitrogen stream, and the unsaponified sample and the alkali-saponified sample were analyzed by HPLC. In addition, for cis isomerization, the MTBE extract was dried under reduced pressure and dissolved in approximately 15 mL of MCT, and cis isomerization by heating was performed in the same manner as in Example 7. The conditions for alkali saponification and HPLC gradient were the same as in Example 7. The results are shown in Figure 6.

[0097] The HPLC chromatogram results shown in Figure 6 indicate that approximately 87% of the pigment components consist of fatty acid ester derivatives of various xanthophylls and carotenes. Specifically, in the unsaponified sample, trans zeaxanthin (maximum absorption wavelength: 451 nm) was the main component as free xanthophyll, followed by trans lutein (maximum absorption wavelength: 445 nm), with small amounts of trans β-cryptoxanthin (maximum absorption wavelength: 452 nm) and small amounts of cis zeaxanthin peaks. In addition, complex peaks were detected in the latter part of the elution. As a result of alkaline saponification, these complex peaks were found to be partly esters of carotenes and xanthophylls (mainly consisting of trans zeaxanthin, lutein, and β-cryptoxanthin). After cis-modification, alkaline saponification was performed, and numerous peaks were observed around the peaks of free zeaxanthin, free lutein, and free β-cryptoxanthin. All of these peaks showed a shift in maximum absorption to a lower wavelength of 5-10 nm, with a cis-isomer-dependent maximum appearing around 330 nm. Therefore, they were considered to be cis-type zeaxanthin, cis-type lutein, and cis-type β-cryptoxanthin. Similar peak variations were also observed in each component of carotene. In summary, it was estimated that approximately 57% of the xanthophylls in the composition were cis-type xanthophylls. However, since cis-type peaks typically shift their maximum absorption to lower wavelengths, the actual proportion of cis-type xanthophylls is likely higher than this figure suggests.

[0098] 11. Investigation of cis-isomerization of crocines (crocetin glycosides) derived from saffron. Approximately 1 g of commercially available saffron (from Spain, House Foods, Japan) was measured out, 50 mL of MeOH was added and mixed well, then 100 mL of chloroform was added and mixed vigorously again. This is called the saffron extract. A portion of this was taken and dried under a nitrogen stream, dissolved in MTBE / MeOH (1:2), and subjected to HPLC analysis. Similarly, a portion was alkali-saponified. As a method, 1 mL of the above extract was taken into a glass screw centrifuge tube, 1 mL of 60% KOH / EtOH was added, and it was mixed vigorously. After mixing, it was treated at 50°C for 1 hour. Immediately after treatment, 3 mL of MTBE, 3 mL of saturated sodium sulfate aqueous solution and 0.3 mL of phosphoric acid were added and mixed vigorously, then centrifuged at 3000 rpm for 10 minutes. After confirming separation into two layers, 3 mL of the upper layer in which the pigment had completely migrated was taken, concentrated as appropriate under a nitrogen stream, and subjected to HPLC analysis. Furthermore, the remaining MTBE / MeOH (1:2) solution was dried under reduced pressure and dissolved in approximately 15 mL of MCT, and cis isomerization by heating was carried out in the same manner as in Example 7. After the reaction, alkali saponification was carried out in the same manner as for the unreacted material. The HPLC gradient conditions and other conditions were as shown in Table 12 below. The HPLC results are shown in Figure 7. (HPLC conditions) HPLC system: LC-2030 (manufactured by Shimadzu Corporation) Detector: Photodiode array detector (300-700nm) Column: YMC Carotenoid, Length: 150mm, Inner diameter: 4.6mm, Particle size: 3μm, Manufactured by YMC. Mobile phase A: 1% phosphate Mobile phase B: Acetonitrile (AcN) Flow rate: 1.0mL / min Detection wavelength: 420nm ** Column temperature: 30℃ Under these conditions, the chromatogram correction is performed based on the peak with the highest height.

[0099] [Table 12]

[0100] As shown in the HPLC chromatogram in Figure 7, multiple peaks were observed in the unsaponified sample, but these were converted to trans-type crocetin by alkaline saponification. Therefore, it was suggested that almost all of the contained pigment components were trans-type crocins, which are glycosides of crocetin. In other words, in the saponified sample, trans-type crocetin (maximum absorption wavelengths: 427 nm, 451 nm) was present as the main component as free xanthophyll. After cis-conversion treatment and subsequent alkaline saponification, numerous peaks were observed around trans-type crocetin. Since the maximum absorption of all these peaks shifted 5-20 nm lower in wavelength from trans-type crocetin, they were considered to be cis-type crocetin. In particular, the peak immediately following all trans-type crocetin had its maximum absorption shifted approximately 5 nm lower in wavelength, and a peak characteristic of cis-type carotenoids was observed at 316 nm, suggesting that it was 13-cis-crocetin. Therefore, it was considered that these were glycosides (crocins) and existed in the cis form. In summary, it was estimated that approximately 49% of the crocins in the composition were cis-type crocins. However, since the maximum absorption of cis-type crocins is usually shifted to lower wavelengths, it is thought that the actual proportion of cis-type crocins is higher than this figure suggests.

Claims

1. A composition containing a cis-type xanthophyll derivative.

2. Furthermore, it contains cis-type xanthophyll, The composition according to claim 1, wherein the molar weight ratio of the cis-type xanthophyll to the cis-type xanthophyll derivative is 0.05 to 1000.

3. The composition according to claim 1, wherein the cis-type xanthophyll derivative comprises one or more cis-type xanthophyll derivatives selected from the group consisting of lipid esters of cis-type xanthophyll, glycosides of cis-type xanthophyll, fatty acid glycosides of cis-type xanthophyll, aliphatic ethers of cis-type xanthophyll, and sulfate esters of cis-type xanthophyll.

4. The composition according to claim 1, wherein the cis-type xanthophyll derivative includes a lipid ester of the cis-type xanthophyll.

5. The composition according to claim 1, wherein the cis-type xanthophyll derivative comprises a lipid ester of cis-type xanthophyll with one or more fatty acids selected from the group consisting of palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, eicosapentaenoic acid, arachidonic acid, and docosahexaenoic acid.

6. The composition according to claim 1, wherein the cis-type xanthophyll derivative comprises one or more cis-type xanthophyll derivatives selected from the group consisting of cis-type lutein derivatives, cis-type zeaxanthin derivatives, and cis-type astaxanthin derivatives.

7. The composition according to claim 1, wherein the cis-type xanthophyll derivative comprises a cis-type lutein derivative.

8. The composition according to claim 1, wherein the cis-type xanthophyll derivative comprises a cis-type zeaxanthin derivative.

9. The composition according to claim 1, wherein the cis-type xanthophyll derivative comprises a cis-type astaxanthin derivative.

10. A pharmaceutical product containing the composition described in claim 1.

11. A food product containing the composition described in claim 1.

12. A cosmetic product containing the composition described in claim 1.

Images